Literature DB >> 2590615

The influence of food on the pharmacokinetics of 'biphasic' nifedipine at steady state in normal subjects.

G H Rimoy1, J R Idle, N K Bhaskar, P C Rubin.   

Abstract

Previous studies following single dose administration have suggested that the pharmacokinetics of various nifedipine formulations could be influenced by the timing of associated food consumption. In order more closely to reflect the clinical situation we have carried out a study at steady state using a 'biphasic' formulation comprising 'rapid' and 'retarded' drug release components. Fifteen normal subjects took 20 mg 'biphasic' nifedipine 12 hourly for 10 days. Studies were carried out on days 4, 7 and 10. On these days the nifedipine was taken 2 h or 1 h before or immediately following a light breakfast. A light breakfast influenced neither the rate nor the extent of nifedipine absorption nor the rate or extent of major metabolite appearance. We conclude that at steady state the timing of a light meal is unlikely to alter in any clinically important manner the pharmacokinetics of nifedipine released from 'biphasic' tablets.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2590615      PMCID: PMC1380025          DOI: 10.1111/j.1365-2125.1989.tb03551.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


  9 in total

1.  Determination of nifedipine and its three principal metabolites in plasma and urine by automated electron-capture capillary gas chromatography.

Authors:  B J Schmid; H E Perry; J R Idle
Journal:  J Chromatogr       Date:  1988-03-04

2.  The effects of food and posture on the pharmacokinetics of a biphasic release preparation of nifedipine.

Authors:  V Challenor; D G Waller; B S Gruchy; A G Renwick; C F George; E T McMurdo; J McEwen
Journal:  Br J Clin Pharmacol       Date:  1986-11       Impact factor: 4.335

3.  Food and nifedipine pharmacokinetics.

Authors:  V F Challenor; D G Waller; B S Gruchy; A G Renwick; C F George
Journal:  Br J Clin Pharmacol       Date:  1987-02       Impact factor: 4.335

4.  The first pass metabolism of nifedipine in man.

Authors:  D G Waller; A G Renwick; B S Gruchy; C F George
Journal:  Br J Clin Pharmacol       Date:  1984-12       Impact factor: 4.335

5.  Human P450PCN1: sequence, chromosome localization, and direct evidence through cDNA expression that P450PCN1 is nifedipine oxidase.

Authors:  F J Gonzalez; B J Schmid; M Umeno; O W Mcbride; J P Hardwick; U A Meyer; H V Gelboin; J R Idle
Journal:  DNA       Date:  1988-03

6.  Nifedipine: kinetics and dynamics after single oral doses.

Authors:  H R Ochs; K D Rämsch; B Verburg-Ochs; D J Greenblatt; J Gerloff
Journal:  Klin Wochenschr       Date:  1984-05-02

7.  Effect of food on nifedipine pharmacokinetics.

Authors:  D P Reitberg; S J Love; G T Quercia; M A Zinny
Journal:  Clin Pharmacol Ther       Date:  1987-07       Impact factor: 6.875

8.  Effect of food ingestion on nifedipine absorption and haemodynamic response.

Authors:  K Hirasawa; W F Shen; D T Kelly; G Roubin; K Tateda; J Shibata
Journal:  Eur J Clin Pharmacol       Date:  1985       Impact factor: 2.953

Review 9.  Influence of food intake on presystemic clearance of drugs.

Authors:  A Melander; A McLean
Journal:  Clin Pharmacokinet       Date:  1983 Jul-Aug       Impact factor: 6.447

  9 in total
  3 in total

Review 1.  Sustained release nifedipine formulations. An appraisal of their current uses and prospective roles in the treatment of hypertension, ischaemic heart disease and peripheral vascular disorders.

Authors:  D Murdoch; R N Brogden
Journal:  Drugs       Date:  1991-05       Impact factor: 9.546

Review 2.  Effects of food on clinical pharmacokinetics.

Authors:  B N Singh
Journal:  Clin Pharmacokinet       Date:  1999-09       Impact factor: 6.447

3.  Food effect on the oral bioavailability of Manidipine: single dose, randomized, crossover study in healthy male subjects.

Authors:  D Rosillon; A Stockis; G Poli; D Acerbi; R Lins; B Jeanbaptiste
Journal:  Eur J Drug Metab Pharmacokinet       Date:  1998 Apr-Jun       Impact factor: 2.441

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.